Hypertensive retinopathy: There's more than meets the eye

Journal of Hypertension

Volumn 23, Issue 4, 2005, Pages 683-696

  Porta, Massimo ^a   Grosso, Andrea ^b   Veglio, Franco ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Cardiovascular risk; Diabetes; Hypertension; Hypertensive retinopathy; Target organ damage

Indexed keywords

CARDIOVASCULAR RISK; DISEASE CLASSIFICATION; DISEASE SEVERITY; EARLY DIAGNOSIS; HUMAN; HYPERTENSION; HYPERTENSION RETINOPATHY; OPHTHALMOSCOPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT INDICATION;

EID: 17144371862     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000163131.77267.11     Document Type: Review

References (134)

1. Chatterjee S, Chattopadhya S, Hope-Ross M, Lip PL. Hypertension and the eye: changing perspectives. J Hum Hypertens 2002; 16:667-675.
2. Guidelines Committee. 2003 European Society of Hypertension/ European Society of Cardiology Guidelines for the Management of Arterial Hypertension. J Hypertens 2003; 21:1011-1053.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr. Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42:1206-1252.
4. World Health Organization/International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) Statement on Management of Hypertension. J Hypertens 2003; 21:1983-1992.
5. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. BHS guidelines working party, for the British Hypertension Society British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328:634-640.
6. Keith NM, Wagener HP, Barker NW. Some different types of essential hypertension: their course and their prognosis. Am J Med Sci 1939; 197:332-343.
7. Klein R, Klein BEK, Moss SE. The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 1997; 95:329-348.
8. Klein R, Klein BEK, Moss SE, Wang Q. Blood pressure, hypertension and retinopathy in a population. Trans Am Ophthalmol Soc 1993; 91:207-222.
9. Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE. A revised method for summarizing retinal vessel diameters. Curr Eye Res 2003; 27:143-149.
10. Sharrett AR, Hubbard LD, Cooper LS, Sorlie PD, Brothers RJ, Nieto FJ, et al. Retinal arteriolar diameters and elevated blood pressure. The Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150:263-270.
11. Hubbard L, Brothers RJ, King WL, Clegg LX, Klein R, Cooper LS, Sharret AR. Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology 1999; 106:2269-2280.
12. Wang JJ, Mitchell P, Leung H, Rochtchina E, Wong TY, Klein R. Hypertensive retinal wall signs in a general older population: The Blue Mountains Eye Study. Hypertension 2003; 42:534-541.
13. Tso M, Jampol Lee M. Pathophysiology of hypertensive retinopathy. Ophthalmology 1982; 89:1132-1145.
14. Wong TY, Klein R, Klein BEK, Tielsch JM, Hubbard L, Nieto FJ. Retinal microvascular abnormalities and their relations with hypertension, cardiovascular diseases and mortality. Surv Ophthalmol 2001; 46: 59-80.
15. Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, et al. Retinal Microvascular Abnormalities and incident stroke. The Atherosclerosis Risk in Communities Study. Lancet 2001; 358:1134-1140.
16. Wong TY, Klein R, Sharret R, Duncan BB, Couper DJ, Tielsch JM, et al. Retinal Arteriolar Narrowing and Risk of Coronary Heart Disease in Men and Women: The Atherosclerosis Risk in Communities Study. JAMA 2002; 287:1153-1159.
17. Cuspidi C, Macca G, Salerno M, Michev L, Fusi V, Severgnini B, et al. Evaluation of target organ damage in arterial hypertension: which role for qualitative fundoscopic examination? Ital Heart J 2001; 2:702-706.
18. Cuspidi C, Salerno M, Salerno DE, Meani S, Valerio C, Esposito A, et al. High prevalence of retinal vascular changes in never-treated essential hypertensives: an inter- and intra-observer reproducibility study with non-mydriatic retinography. Blood Press 2004; 13:25-30.
19. Lip GYH, Bevers M, Beevers G. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens 1995; 13:915-924.
20. Coll de Tuero G, Foguet Boreu Q, Vargas Vila S, Saez Zafra M, Barcelo Rado MA. The usefulness of ophthalmoscopy in risk evaluation of hypertensive patients. Blood Press 2002; 11:263-269.
21. Klein BEK, Davis MD, Segal P, Long JA, Harris WA, Haug GA, et al. Diabetic retinopathy: assessment of severity and progression. Ophthalmology 1984; 91:10-17.
22. Palmberg P, Smith M, Waltman S, Krupin T, Singer P, Burgess D, et al. The natural history of retinopathy in insulin-dependent juvenile-onset diabetes. Ophthalmology 1981; 88:613-618.
23. Moss SE, Klein R, Kessler SD, Richie KA. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology 1985; 92:62-67.
24. Sussman EJ, Tsiaras WG, Soper KA. Diagnosis of diabetic eye disease. JAMA 1982; 247:3231-3234.
25. Porta M, Rizzitiello A, Tomalino M, Trento M, Passera P, Minonne A, et al. A comparison of the cost-effectiveness of three approaches to screen for sight-threatening diabetic retinopathy. Diabetes Metab 1999; 25: 44-53.
26. Scheie HG. Evaluation of ophthalmoscopic changes of hypertension and arteriolar sclerosis. Arch Ophthalmol 1953; 49:117-138.
27. Dimmit SB, West JN, Eames SN, Gibson JM, Gosling P, Littler WA. Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet 1989; 1:1103-1106.
28. Fuchs FD, Maestri MK, Bredemeier M, Cardozo SE, Moreira FC, Wainstein MV, et al. Study of the usefulness of optic fundi examination of patients with hypertension in a clinical setting. J Hum Hypertens 1995; 9:547-551.
29. Bursell SE, Cavallerano JD, Cavallerano AA, Clermont AC, Birkmire-Peters D, Aiello LP, Aiello LM. Stereo nonmydriatic digital-video retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 2001; 108:572-585.
30. Gardner GG, Keating D, Williamson TH, Elliott AT. Automatic detection of diabetic retinopathy using an artificial neural network: a screening tool. Br J Ophthalmol 1996; 80:940-944.
31. Couper DJ, Klein R, Hubbard L, Wong Ty, Sorlie PD, Cooper LS. Reliability of retinal photography in the assessment of retinal microvascular characteristics. The Atherosclerosis Risk in Communities Study. Am J Ophthalmol 2002; 133:78-88.
32. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Klein BE, et al. Atherosclerosis Risk in Communities Study Retinal arteriolar diameter and risk for hypertension. Ann Intern Med 2004; 140: 248-255.
33. Wong TY, Shankar A, Klein R, Klein B, Hubbard L. Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ 2004; 329:79.
34. Wong TY, Hubbard LD, Klein R, Marino EK, Kronmal R, Sharrett AR, et al. Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol 2002; 86:1007-1013.
35. Klein R, Sharrett AR, Klein BE, Chambless LE, Cooper LS, Hubbard LD, Evans G. Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 2000; 20:1644-1650.
36. Conlan MG, Folsom AR, Finch A. Associations of factor VIII and von Willebrand factor with age, race, sex and risk factors for atherosclerosis. Thromb Haemost 1993; 70:380-385.
37. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340:448-454.
38. Mannucci PM. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998; 18:1359-1362.
39. Kessler L, Wiesel ML, Attali P, Mossard JM, Cazenave JP, Pinget M. Von Willebrand factor in diabetic angiopathy. Diabetes Metab 1998; 24:327-336.
40. Wong TY, Klein R, Klein BE, Meuer SM, Hubbard LD. Retinal vessel diameters and their associations with age and blood pressure. The Blue Mountains Eye Study Invest. Ophthalmol Vis Sci 2003; 44:4644-4650.
41. Leppala JM, Virtamo J, Fogelholm R, Albanes D, Heinonen OP. Different risk factors for different stroke subtypes: associations of blood pressure, cholesterol, and antioxidants. Stroke 1999; 30:2535-2540.
42. Laurent S, Katsahian S, Fassot C, Tropeano AI, Gautier I, Laloux B, Boutouyrie P. Aortic stiffness is an indipendent predictor of fatal stroke in essential hypertension. Stroke 2003; 34:1203-1206.
43. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor? Am J Epidemiol 1994; 140:669-682.
44. Hodes RJ, Lakatta EG, McNeil CT. Another modifiable risk factor for cardiovascular disease? Some evidence points on arterial stiffness. J Am Geriatr Soc 1995; 43:581-582.
45. Arnett DK, Boland LL, Evans GW, Rley W, Barnes R, Tyrole HA, Heiss G. Hypertension and arterial stiffness: The Atherosclerosis Risk in Communities Study. Am J Hypertens 2000; 13:317-323.
46. Laurent S, Boutoyrie P, Asmar R, Gautier I, Laloux B, Guize L. Aortic stiffness is an indipendent predictor of all-cause mortality in hypertensive patients. Hypertension 2001; 37:1236-1241.
47. Blacher J, Pannier B, Guerin AP, Matchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all cause mortality in end stage renal disease. Hypertension 1998; 32:570-574.
48. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99:2434-2439.
49. Liao D, Wong TY, Klein R, Jones D, Hubbard L, Sharrett R. Relationship between carotid artery stiffness and retinal arteriolar narrowing in healthy middle-aged persons. Stroke 2004; 35:837-842.
50. Wong TY, Klein R, Sharret R, Couper D, Klein B, Liao DP, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002; 288:67-74.
51. Chilian WM. Coronary microcirculation in health and disease: summary of an NHLBI workshop. Circulation 1990; 82:1-7.
52. Vaccarino V, Pearsons L, Every NR, Barron HV, Krumholz HM. for the National Registry of Myocardial Infarction 2 participants. Sex-based differences in early mortality after myocardial infarction. N Engl J Med 1999; 341:217-225.
53. Maguire MG. Explaining gender differences in coronary heart disease: hunting for clues with the ophthalmoscope. Arch Ophthalmol 2003; 121:1328-1329.
54. Duncan BB, Wong TY, Tyroler HA, Dvis CE, Fuchs FD. Hypertensive retinopathy and incident coronary heart disease in high risk men. Br J Ophthalmol 2002; 86:1002-1006.
55. Muiesan ML, Salvetti M, Rizzoni D, Castellano M, Donato F, Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertens 1995; 13:1091-1095.
56. Ogden LG, He J, Lydick E, Whelton PK. Long term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 2000; 35:539-543.
57. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Sixth Report. Arch Intern Med 1997; 157:2413-2446.
58. 1999 World Health Organization-International, Society of Hypertension Guidelines for the management of Hypertension. J Hypertens 1999; 17:151-183.
59. Schillaci G, de Simone G, Reboldi G, Porcellati C, Devereux R, Verdecchia P. Change in cardiovascular risk profile by echocardiography in low- or medium-risk hypertension. J Hypertens 2002; 20:1519-1525.
60. Dahlof B, Stenkula S, Hansson L. Hypertensive retinal vascular changes. Relationship to left ventricular hypertrophy and arteriolar changes before and after treatment. Blood Press 1992; 1:35-44.
61. Fea A, Veglio F, Grosso A, Rabbia F, Cardillo-Piccolino F, Grosso T, et al. Comparison between retinal microvascular abnormalities and target organ damage in young untreated mild hypertensive patients [Abstract]. Eur J Ophthalmol 2003; 13:223.
62. Skoog I, Lemfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, et al. 15 year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-1145.
63. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H. Hypertension is related to cognitive impairment. A 20 year follow-up of 999 men. Hypertension 1918; 31:780-786.
64. Tzourio C, Dufouil C, Ducimetiere P, Alperovitch A. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly: EVA Study Group Epidemiology of Vascular Aging. Neurology 1999; 53:1948-1952.
65. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, et al. Cardiovascular risk factors and cognitive impairment in middle-aged adults. Neurology 2001; 56:42-48.
66. Zhu L, Fratiglioni L, Quo Z, Aguero-Torres H, Inblad B, Viitanen M. Association of stroke with dementia, cognitive impairment and functional disability in the very hold: a population based study. Stroke 1998; 29:2094-2099.
67. Rockwood K, Wentzel C, Hachinsky V, Hogan DB, MacKnight C, McDowell I. Prevalence and outcomes of vascular cognitive impairment: Vascular Cognitive Impairment Investigators of the Canadian Study of Health and Aging. Neurology 2000; 54:447-451.
68. Hachinski V, Munoz DG. Cerebrovascular pathology in Alzheimer'sdisease: cause, effect or epiphenomenon? Ann NY Acad Sci 1997; 826:1-6.
69. Hachinski V, Munoz DG. Vascular factors in cognitive impairment: where are we now? Ann NY Acad Sci 2000; 903:1-5.
70. Wong TY, Klein R, Sharret R, Nieto FJ, Boland LL, Couper DJ, et al. Retinal microvascular abnormalities and cognitive impairment in middle aged persons. The Atherosclerosis Risk in Communities Study. Stroke 2002; 33:1487-1492.
71. Bonte FJ, Ross ED, Chehabi HH, Devous MD. SPECT study of regional cerebral blood flow by SPECT in Alzheimer disease. J Comput Assist Tomogr 1986; 10:579-586.
72. Weinstein HC, Hijdra A, Van Rojen EA, Derix MM. Determination of cerebral blood flow by SPECT: a valuable tool in the investigation in dementia? Clin Neurol Neurosurg 1989; 91:13-19.
73. Goto I, Kimoto K, Katsuki S, Mimatsu T, Ikui H. Pathological studies on the intracerebral and retinal arteries in cerebrovascular and non-cerebrovascular diseases. Stroke 1985; 16:773-780.
74. Liao D, Cooper L, Cai J, Toole J, Bryan N, Burke G, et al. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 1997; 16:149-162.
75. Tanaka H, Hayashi M, Date C, Imai K, Asada M, Shoji H, et al. Epidemiologic studies of stroke in Shibata, a Japanese provincial city: preliminary report on risk factors for cerebral infarction. Stroke 1985; 16:773-780.
76. Nakayama T, Date C, Yokoyama T, Yoshiike N, Yamaguchi M, Tanaka H. A 15.5 year follow up study of stroke in a Japanese provincial city. The Shibata Study. Stroke 1997; 28:45-52.
77. Schneider R, Rademacher M, Wolf S. Lacunar infarcts and white matter attenuation: ophthalmologic and microcirculatory aspects of the pathophysiology. Stroke 1993; 24:1874-1879.
78. Kobayashi S, Okada K, Koide H, Bokura H, Yamaguchi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997; 28:1932-1939.
79. van Swieten JC, van den Hout JH, van Ketel BA, Hjidra A, Wokke JH, van Gjin J. Periventricular lesions in the white matter on magnetic resonance imaging in the elderly: a morphometric correlation with arteriolosclerosis and dilated perivascular spaces. Brain 1991; 114:761-774.
80. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43:1683-1689.
81. Moody DM, Brown WR, Challa VR, Ghazy-Birry HS, Reboussin DM. Cerebral microvascular alterations in aging, leukoaraiosis and Alzheimer's disease. Ann NY Acad Sci 1997; 826:103-116.
82. van Swieten JC, Geyskes GG, Derix MMA, Peeck BM, Romos LMP, van Gjin J. Hypertension in the elderly associated with white matter lesions and cognitive decline. Ann Neurol 1991; 30:825-830.
83. Goldstein IB, Bartzokis G, Hance DB, Shapiro D. Relationship between blood pressure and subcortical lesions in healthy elderly people. Stroke 1998; 29:765-772.
84. Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, Tyroler HA. Presence and severity of cerebral white matter lesions and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996; 27:2262-2270.
85. Dufouil C, de Kersaint-Gilly A, Besancon V, Levy C, Auffray E, Brunnereau L, et al. Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology 2001; 56:921-926.
86. Perros P, Deary U, Sellar RJ, Best JJ, Frier BM. Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycaemia. Diabetes Care 1997; 20:1013-1018.
87. Manolio TA, Burke GL, O'Leary DH, Evans G, Beauchamp N, Knepper L, Ward B. Relationship of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: The Cardiovascular Health Study CHS Collaborative Research Group. Arterioscler Thromb Vasc Biol 1999; 19:356-365.
88. Streifler JY, Eliasziw M, Benavente OR, Hachinsky VC, Fox AJ, Barnett HJM. Lack of relationship between leukoaraiosis and carotid artery disease. The North American Symptomatic Carotid Endarterectomy Trial. Arch Neurol 1995; 52:21-24.
89. Wong TY. Is retinal photography useful in the measurement of stroke risk? Lancet Neurol 2004; 3:179-183.
90. Heidbreder E, Huller U, Schafer B, Heidland A. Severe hypertensive retinopathy. Increased incidence in renoparenchymal hypertension. Am J Nephrol 1987; 7:394-400.
91. Biesenbach G, Zazgornik J. High prevalence of hypertensive retinopathy and coronary heart disease in hypertensive patients with persistent microalbuminuria under short intensive antihypertensive therapy. Clin Nephrol 1994; 41:211-218.
92. Pontremoli R, Cheli V, Sofia A, Tirotta A, Ravera M, Nicolella C, et al. Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. Nephrol Dial Transplant 1995; 10:6-9.
93. Pontremoli R, Sofia A, Ravera M, Nicolella C, Viazzi F, Tirotta A, et al. Prevalence and clinical correlates of microalbuminuria in essential hypertension. The MAGIC Study. Microalbuminuria: A Genoa I nvestigation on Complications. Hypertension 1997; 30:1135-1143.
94. Cruickshanks KJ, Ritter LL, Klein R, Moss SE. The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 1993; 100:862-867.
95. Klein R, Klein B, Moss SE, Cruickshanks KJ. Ten year incidence of gross proteinuria in people with diabetes. Diabetes 1995; 44:916-923.
96. Klein R, Klein B, Moss SE, Cruickshanks KJ, Brazy PC. The 10 year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care 1999; 22:743-751.
97. Wirta O, Pasternack A, Mustonenen J, Leipala P, Lahde Y. Retinopathy is independently related to microalbuminuria in type 2 diabetes mellitus. Clin Nephrol 1999; 51:329-333.
98. Wong TY, Shankar A, Klein R, Klein BE. Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. Diabetes 2004; 53:179-184.
99. Carlson EC. Sanning and transmission electron microscopic studies of normal and diabetic acellular glomerular and retinal microvessel basement membranes. Microscopy Res Tech 1994; 28:165-177.
100. Jensen T, Deckert T. Diabetic retinopathy, nephropathy and neuropathy. Generalized vascular damage in insulin-dependent diabetic patients. Horm Metab Res 1992; 26:68-70.
101. Skyler JS. Microvascular complications: retinopathy and nephropathy. Endocr Metab Clin North Am 2004; 30:833-856.
102. Raine AE, Bilous RW. End stage renal disease in NIDDM: a consequence of microangiopathy alone? Diabetologia 1996; 39:1673-1675.
103. Ford ES, Giles W, Dietz WH. Prevalence of the metabolic syndrome among US adults. JAMA 2002; 287:356-369.
104. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS Report Number 12. Ophthalmology 1991; 98:823-833.
105. Porta M, Bandello F. Diabetic retinopathy. A clinical update. Diabetologia 2002; 45:1617-1634.
106. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998; 105:1801-1815.
107. Porta M, Sjoelie A-K, Chaturvedi N, Stevens L, Rottiers R, Veglio M, Fuller JH, and the EURODIAB Prospective Complications Study Group. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia 2001; 44:2203-2209.
108. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38. BMJ 1998; 317:703-713.
109. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003; 26:333-350.
110. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis. Diabetes Care 1992; 15:815-819.
111. Wong TY, Klein R, Sharrett AR, Schmidt MI, Pankow JS, Couper DJ, et al. Retinal arteriolar narrowing and risk of diabetes in middle-aged persons. JAMA 2002; 287:2528-2533.
112. Klein R, Klein BE, Moss SE, Wong TY, Hubbard L, Cruickshanks KJ, Palta M. Retinal vascular abnormalities in persons with type 1 diabetes: The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVIII. Ophthalmology 2003; 110:2118-2125.
113. Klein R, Klein BE, Moss SE, Wong TY, Hubbard L, Cruickshanks KJ, Palta M. The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX the Wisconsin Diabetic Retinopathy. Arch Ophthalmol 2004; 122:76-83.
114. Keen H, Chlouverakis C. Metabolic factors in diabetic retinopathy. In: Graymore CN (editor): Biochemistry of the retina. London: Academic Press; 1965, pp. 123-138.
115. Breslin DJ, Gifford RW, Fairbairn JF, Kearns TP. Prognostic importance of ophthalmoscopic findings in essential hypertension. JAMA 1966; 195:335-338.
116. Svardsudd K, Wedel H, Aurell E, Tibblin G. Hypertensive eye ground changes. Prevalence, relation to blood pressure, and prognostic importance. The men born in 1913. Acta Med Scand 1978; 204:159-167.
117. Ralph RA. Prediction of cardiovascular status from arteriovenous crossing phenomena. Ann Ophthalmol 1974; 6:323-326.
118. Palmer RS, Loofbourow D, Doeing CR. Prognosis in essential hypertension: eight year follow-up study of 430 patients on conventional medical treatment. N Engl J Med 1948; 239:990-994.
119. Oglesby P, Lepper MH, Phelan WH. A longitudinal study of coronary heart disease. Circulation 1963; 28:20-31.
120. Michelson IC, Morganroth J, Nichols CW, MacVaugh H 3rd. Retinal arteriolar changes as an indicator of coronary artery disease. Arch Intern Med 1979; 139:1139-1141.
121. Luo BP, Brown G. Update on the ocular manifestations of systemic arterial hypertension. Curr Opin Ophthalmol 2004; 15:203-210.
122. Walsh J. Hypertensive retinopathy: description, classification, and prognosis. Ophthalmology 1982; 92:45-59.
123. Wong TY, Klein R, Nieto FJ, Wong TY, Klein R, Nieto FJ, et al. Retinal microvascular abnormalities and ten-year cardiovascular mortality. A population-based case-control study. Ophthalmology 2003; 110:933-940.
124. Wong TY, Knudtson MD, Klein R, Klein BEK, Hubbard LD. A prospective cohort study of retinal arteriolar narrowing and mortality. Am J Epidemiol 2004; 159:819-825.
125. Hayreh S. Duke-elder lecture: systemic arterial blood pressure and the eye. Eye 1996; 10:5-28.
126. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Hagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995; 25:474-481.
127. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation 2001; 104:735-740.
128. Rizzoni TD, Porteri E, Boari GEM, De Ciuceis C, Sleiman I, Muiesan ML, et al. Prognostic significance of small-artery structure in hypertension. Circulation 2003; 108:2230-2235.
129. Ruilope LM, Schiffrin EL. Blood pressure control and benefits of antihypertensive therapy: does it make a difference which agents we use? Hypertension 2001; 38:537-542.
130. Bressler NM. Retinal arteriolar narrowing and risk of coronary heart disease. Arch Ophthalmol 2003; 121:113-114.
131. Saitoh M, Matsuo K, Nomoto S, Kondoh T, Yanagawa T, Katoh Y, Hasegawa K. Relationship between left ventricular hypetrophy and renal and retinal damage in untreated patients with essential hypertension. Intern Med 1998; 37:576-580.
132. Sharp PS, Chaturvedi N, Wormald R, McKeigue PM, Marmot MG, Young SM. Hypertensive retinopathy in Afro-Caribbeans and Europeans. Prevalence and risk factor relationships. Hypertension 1995; 25:1322-1325.
133. Palatini P, Penzo M, Bongiovi S, Canali C, Pessina AC. Role of ophthalmoscopy in arterial hypertension: a problem revisited. Cardiologia 1991; 36:713-722.
134. O'Sullivan P, Hickey N, Maurer B, Guinan P, Mulcahy R. Retinal artery changes correlated with other hypertensive parameters in a coronary heart disease case-history study. Br Heart J 1968; 30:556-562.